MELA Sciences Announces Election Of R. Rox Anderson, M.D., To Board Of Directors

HORSHAM, Pa., Oct. 13, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (NASDAQ:MELA), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, announced today that R. Rox Anderson, M.D., was elected to the Company's board of directors at its Annual General Meeting of Stockholders held on September 30, 2015 in Philadelphia, PA. With Dr. Anderson's election, the MELA board of directors has increased to seven members, six of whom are independent.

Jeffrey F. O'Donnell, Chairman of the MELA Board, stated, "Having Dr. Anderson on our Board benefits MELA in so many ways, not the least of which is that Dr. Anderson led the team that developed the first XTRAC ® system at Massachusetts General Hospital. He is very familiar with the product, its history and potential. The Board will benefit from his knowledge and counsel. On a personal level, I am very pleased to have the opportunity to work with him again."

"We are delighted to have Dr. Anderson as a member of MELA's board of directors," said Michael R. Stewart, MELA's President and CEO. "Dr. Anderson is a key thought leader in the treatment of dermatological disorders, and conceived and developed many of the non-scarring laser treatments now widely used in dermatology. He has an extensive academic background and impeccable reputation. His significant knowledge and accomplishments in photomedicine will be invaluable to the Company as we integrate our recent acquisition of the XTRAC and VTRAC ® businesses and seek new areas of growth in dermatology." 

"I am excited to have joined MELA's Board at this stage in the Company's development," said Dr. Anderson. "I am very familiar with the recently acquired XTRAC and VTRAC systems and believe that MELA is now poised to become an important commercial player in dermatology.  I look forward to assisting the Company in achieving that status."

If you liked this article you might like

3 Stocks Under $10 Making Big Moves

4 Stocks Under $10 Making Big Moves Higher

Weak On High Volume: Mela (MELA)

3 Stocks Pushing The Health Services Industry Lower

5 Stocks Under $10 Set to Soar